Severe FECD increases risk of glaucoma and OHT

Article

Severe Fuchs endothelial corneal dystrophy (FECD) increases the risk of developing glaucoma and/or ocular hypertension (G/OHT).

Severe Fuchs endothelial corneal dystrophy (FECD) increases the risk of developing glaucoma and/or ocular hypertension (G/OHT).

Dr Mehul Nagarsheth et al., Wills Eye Institute/Jefferson Medical College, Philadelphia, Pennsylvania, USA, studied a subset of 1610 from the FECD Genetics Multi-Centre Study. Logistic regression models, adjusted for age, sex, central corneal thickness, IOP, presence of diabetes and time of day of the initial evaluation, were used.

Of the total eyes included in the study, 107 eyes had G/OHT and the prevalence of G/OHT in the control group was 6%. Eyes with a grade of four through to six were more likely to have concurrent G/OHT than eyes with no record of FECD.

Prevalence of G/OHT was lower in index cases with an FECD grade of one to three and family members with a grade of zero through to three. But it was higher in index cases and family members with a grade of four to six. The logistic regression models demonstrated no correlation between sex, diabetes, time of day of evaluation and central corneal thickness with prevalence of G/OHT.

The abstract can be found in the journal Archives of Ophthalmology.

Recent Videos
(Image credit: Ophthalmology Times Europe) AGS 2025: Clemens Strohmaier, PhD, on improving aqueous humour outflow following excimer laser trabeculostomy
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
Vikas Chopra at AAO 2024: Advancements in MIGS are transforming patient care
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
© 2025 MJH Life Sciences

All rights reserved.